Qube Research & Technologies LTD Lifevantage Corp Transaction History
Qube Research & Technologies LTD
- $82.3 Billion
- Q1 2025
A detailed history of Qube Research & Technologies LTD transactions in Lifevantage Corp stock. As of the latest transaction made, Qube Research & Technologies LTD holds 55,916 shares of LFVN stock, worth $719,079. This represents 0.0% of its overall portfolio holdings.
Number of Shares
55,916
Previous 45,346
23.31%
Holding current value
$719,079
Previous $795,000
2.52%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding LFVN
# of Institutions
109Shares Held
6.44MCall Options Held
24.3KPut Options Held
15.8K-
Jim Simons Renaissance Technologies LLC | New York, Ny864KShares$11.1 Million0.02% of portfolio
-
Capital Management Corp716KShares$9.2 Million2.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA489KShares$6.29 Million0.0% of portfolio
-
Driehaus Capital Management LLC Chicago, IL460KShares$5.91 Million0.07% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT419KShares$5.38 Million0.03% of portfolio
About Lifevantage Corp
- Ticker LFVN
- Exchange NASDAQ
- Sector Consumer Defensive
- Industry Packaged Foods
- Shares Outstandng 12,560,000
- Market Cap $162M
- Description
- LifeVantage Corporation engages in the identification, research, development, formulation, sale, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care products, bath and body, and targeted relief products. The company offers Protandim, a line of scientifically va...